Experience. Commitment. Results.
Altimar Acquisition Corp. (ATAC) relating to its proposed merger with Owl Rock Capital Group and Dyal Capital Partners. Under the terms of the agreement, Owl Rock and Dyal will combine into ATAC and emerge as a newly traded public company on the New York Stock Exchange.
PRGX Global, Inc. (PRGX) relating to its proposed acquisition by Adrian, a French private equity firm. Under the terms of the agreement, PRGX shareholders will receive $7.71 in cash per share.
Harvest Capital Credit Corp. (HCAP) relating to its proposed acquisition by Portman Ridge Finance Corporation. Under the terms of the agreement, Harvest shareholders will receive a combination of cash and Portman common stock per share.
Pluralsight, Inc. (PS) relating to its proposed acquisition by affiliates of Vista Equity Partners VII, LP. Under the terms of the agreement, Pluralsight’s shareholders will receive $20.26 in cash per share.
Nielsen Holdings plc (NLSN) relating to its agreement to sell Nielsen’s Global Connect business to Advent International Corporation for approximately $2.7 billion in cash.
Seneca Biopharma, Inc. (SNCA) relating to its proposed merger with Leading BioSciences, Inc. (“LBS”). Under the terms of the merger agreement, LBS shareholders will be issued Seneca common stock and Seneca shareholders will receive one contingent value right as a dividend for each share they own. Seneca shareholders will only control 26.2% of the combined … Read more
Aerojet Rocketdyne Holdings, Inc. (NYSE: AJRD), relating to its proposed acquisition by L3Harris Technologies, Inc. Under the terms of the agreement, AJRD shareholders are expected to receive $58.00 in cash per share they own.
FinServ Acquisition Corp. (FSRV) relating to its proposed merger with Katapult Holding, Inc. (“Katapult”). Under the terms of the agreement, FinServ will acquire Katapult through a reverse merger that will result in Katapult becoming a publicly traded company.
NantKwest, Inc. (NK) relating to its proposed merger with ImmunityBio. Under the terms of the agreement, ImmunityBio shareholders will receive 0.8190 shares of NatKwest per share they own.
New Providence Acquisition Corp. (NPA) relating to its proposed reverse merger with AST & Science LLC (“AST”). Under the terms of the agreement, NPA will acquire AST through a reverse merger that will result in AST becoming a publicly traded company.